Medtronic logo

MDT - Medtronic Share Price

$119.03 0.2  0.1%

Last Trade - 17/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £122.65bn
Enterprise Value £134.47bn
Revenue £23.75bn
Position in Universe 53rd / 6410
Bullish
Bearish
Unlock MDT Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MDT Revenue Unlock MDT Revenue

Net Income

MDT Net Income Unlock MDT Revenue

Normalised EPS

MDT Normalised EPS Unlock MDT Revenue

PE Ratio Range

MDT PE Ratio Range Unlock MDT Revenue

Dividend Yield Range

MDT Dividend Yield Range Unlock MDT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MDT EPS Forecasts Unlock MDT Revenue
Profile Summary

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Directors
Last Annual April 26th, 2019
Last Interim October 25th, 2019
Incorporated June 12, 2014
Public Since March 17, 1980
No. of Shareholders: 25,797
No. of Employees: 90,071
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Global 100, S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 1,340,377,511
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MDT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MDT
Upcoming Events for MDT
Similar to MDT
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.